According to IDEXX Laboratories's latest financial reports the company has $0.13 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.11 B | -22.09% |
2021-12-31 | $0.14 B | -62.37% |
2020-12-31 | $0.38 B | 325.05% |
2019-12-31 | $90.32 M | -27.04% |
2018-12-31 | $0.12 B | -73.77% |
2017-12-31 | $0.47 B | 20.44% |
2016-12-31 | $0.39 B | 14.38% |
2015-12-31 | $0.34 B | 6.22% |
2014-12-31 | $0.32 B | 15.58% |
2013-12-31 | $0.27 B | 24.59% |
2012-12-31 | $0.22 B | 21.8% |
2011-12-31 | $0.18 B | 17.19% |
2010-12-31 | $0.15 B | 47.02% |
2009-12-31 | $0.10 B | 35.32% |
2008-12-31 | $78.86 M | 30.66% |
2007-12-31 | $60.36 M | -37.56% |
2006-12-31 | $96.66 M | -27.17% |
2005-12-31 | $0.13 B | -3.31% |
2004-12-31 | $0.13 B | -37.8% |
2003-12-31 | $0.22 B | 49.94% |
2002-12-31 | $0.14 B | 85.01% |
2001-12-31 | $79.55 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Abbott Laboratories ABT | $9.53 B | 7,075.66% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | $3.13 B | 2,258.51% | ๐บ๐ธ USA |
![]() Henry Schein
HSIC | $0.13 B | 3.13% | ๐บ๐ธ USA |
![]() Meridian Bioscience VIVO | $81.45 M | -38.68% | ๐บ๐ธ USA |
![]() Neogen NEOG | $0.24 B | 84.86% | ๐บ๐ธ USA |
![]() Heska Corporation
HSKA | $0.12 B | -5.74% | ๐บ๐ธ USA |
![]() Petco WOOF | $0.14 B | 12.12% | ๐บ๐ธ USA |